TWO SIGMA ADVISERS, LP - HARVARD BIOSCIENCE INC ownership

HARVARD BIOSCIENCE INC's ticker is HBIO and the CUSIP is 416906105. A total of 96 filers reported holding HARVARD BIOSCIENCE INC in Q3 2023. The put-call ratio across all filers is 0.56 and the average weighting 0.2%.

Quarter-by-quarter ownership
TWO SIGMA ADVISERS, LP ownership history of HARVARD BIOSCIENCE INC
ValueSharesWeighting
Q3 2023$795,741
+16.1%
185,056
+48.2%
0.00%0.0%
Q2 2023$685,459
+78.3%
124,856
+36.4%
0.00%
+100.0%
Q1 2023$384,535
-9.1%
91,556
-40.1%
0.00%0.0%
Q4 2022$423,134
-22.5%
152,756
-28.4%
0.00%
-50.0%
Q3 2022$546,000
-3.2%
213,240
+36.1%
0.00%0.0%
Q2 2022$564,000
-45.6%
156,656
-6.2%
0.00%
-33.3%
Q1 2022$1,037,000
-41.4%
166,956
-33.5%
0.00%
-25.0%
Q4 2021$1,771,000
-15.4%
251,156
-16.3%
0.00%
-20.0%
Q3 2021$2,094,000
-16.8%
299,956
-0.8%
0.01%
-28.6%
Q2 2021$2,518,000
+173.7%
302,256
+79.3%
0.01%
+133.3%
Q1 2021$920,000
+52.1%
168,556
+19.5%
0.00%
+50.0%
Q4 2020$605,000
+124.1%
141,056
+57.3%
0.00%
+100.0%
Q3 2020$270,000
-0.4%
89,656
+2.4%
0.00%0.0%
Q2 2020$271,000
+37.6%
87,556
-2.0%
0.00%0.0%
Q1 2020$197,000
-37.1%
89,356
-12.9%
0.00%0.0%
Q4 2019$313,000
-24.0%
102,556
-23.4%
0.00%0.0%
Q3 2019$412,000
+205.2%
133,856
+97.8%
0.00%
Q2 2019$135,000
+35.0%
67,656
+190.9%
0.00%
Q1 2019$100,000
+33.3%
23,256
-0.9%
0.00%
Q4 2018$75,000
-44.9%
23,456
-9.3%
0.00%
Q3 2018$136,000
+9.7%
25,856
+11.2%
0.00%
Q2 2018$124,000
+2.5%
23,244
-3.8%
0.00%
Q1 2018$121,000
+51.2%
24,156
-0.8%
0.00%
Q4 2017$80,000
-13.0%
24,356
-0.8%
0.00%
Q3 2017$92,000
+43.8%
24,556
-2.0%
0.00%
Q2 2017$64,000
-1.5%
25,0560.0%0.00%
Q1 2017$65,000
-21.7%
25,056
-7.4%
0.00%
Q4 2016$83,000
+12.2%
27,056
-0.4%
0.00%
Q3 2016$74,000
-14.9%
27,156
-10.8%
0.00%
Q2 2016$87,000
-8.4%
30,456
-2.9%
0.00%
-100.0%
Q1 2016$95,000
-17.4%
31,356
-5.4%
0.00%0.0%
Q4 2015$115,000
+30.7%
33,156
+43.2%
0.00%0.0%
Q3 2015$88,000
-29.6%
23,156
+5.5%
0.00%0.0%
Q2 2015$125,000
-11.3%
21,956
-9.5%
0.00%0.0%
Q1 2015$141,000
+2.2%
24,2560.0%0.00%0.0%
Q4 2014$138,000
+9.5%
24,256
-21.5%
0.00%0.0%
Q3 2014$126,000
-25.9%
30,900
-17.2%
0.00%0.0%
Q2 2014$170,000
+73.5%
37,300
+79.3%
0.00%0.0%
Q1 2014$98,000
+63.3%
20,800
+62.5%
0.00%0.0%
Q4 2013$60,000
-11.8%
12,8000.0%0.00%0.0%
Q3 2013$68,000
+33.3%
12,800
+18.5%
0.00%0.0%
Q2 2013$51,00010,8000.00%
Other shareholders
HARVARD BIOSCIENCE INC shareholders Q3 2023
NameSharesValueWeighting ↓
AMH Equity Ltd 2,053,907$8,626,4099.88%
B. Riley Asset Management, LLC 3,408,796$14,316,9435.93%
Meros Investment Management, LP 1,124,206$4,721,6652.69%
Harvey Partners, LLC 2,712,700$11,393,3401.41%
Archon Capital Management LLC 1,361,769$5,719,4301.28%
PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. 2,947,329$12,378,7820.80%
BARD ASSOCIATES INC 291,297$1,223,4480.50%
Portolan Capital Management 1,043,546$4,382,8930.42%
HEARTLAND ADVISORS INC 1,200,000$5,040,0000.31%
EAM Investors, LLC 345,546$1,451,2930.28%
View complete list of HARVARD BIOSCIENCE INC shareholders